Journal
JORNAL BRASILEIRO DE NEFROLOGIA
Volume 43, Issue 4, Pages 572-579Publisher
SOC BRASILEIRA NEFROLOGIA
DOI: 10.1590/2175-8239-JBN-2020-U002
Keywords
Hyperuricemia; Uric Acid; Acute Kidney Injury; Renal Insufficiency; Chronic; Allopurinol; Cardiovascular Disease
Categories
Ask authors/readers for more resources
Hyperuricemia is common in CKD and may cause kidney damage, but causal relationship between uric acid and CKD remains unclear. Experimental studies suggest uric acid can lead to kidney injury.
Hyperuricemia is common in chronic kidney disease (CKD) and may be present in 50% of patients presenting for dialysis. Hyperuricemia can be secondary to impaired glomerular filtration rate (GFR) that occurs in CKD. However, hyperuricemia can also precede the development of kidney disease and predict incident CKD. Experimental studies of hyperuricemic models have found that both soluble and crystalline uric acid can cause significant kidney damage, characterized by ischemia, tubulointerstitial fibrosis, and inflammation. However, most Mendelian randomization studies failed to demonstrate a causal relationship between uric acid and CKD, and clinical trials have had variable results. Here we suggest potential explanations for the negative clinical and genetic findings, including the role of crystalline uric acid, intracellular uric acid, and xanthine oxidase activity in uric acid-mediated kidney injury. We propose future clinical trials as well as an algorithm for treatment of hyperuricemia in patients with CKD.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available